Karen Drexler
Founder of EXXclaim Capital, and Board Member of Naia Health, Sandstone Diagnostics, Hygieia Medical, and diaDexus

Karen has 30 years of experience as a Life Science Executive and Entrepreneur. She was an early employee of LifeScan, helped build the company from zero to $1 billion in revenues and played an essential role in selling the company to Johnson & Johnson. She held operating and executive roles across LifeScan in marketing, sales, manufacturing operations and new product planning.

After leaving LifeScan, Karen founded and ran Amira Medical, an innovative company in the diabetes space. She was President and CEO until she sold the company to Roche in 2001.

During the past 14 years, Karen has held board member, board chair and acting CEO roles in numerous private and public medtech companies, several of which she also co-founded. Karen is currently a board observer and advisor to nVision, a women’s health device and diagnostic company, a board member and advisor to Naia, an innovative breast pump and mobile platform company, and a board member of Sandstone, which is developing an OTC male fertility test, all in the Bay Area. She is chair of the board of Hygieia, a health services company, and board member and chair of the compensation committee for diaDexus, a public diagnostics company.

Karen is also a co-founder and partner of EXXclaim Capital Management, a venture fund that is focused on investing in innovations in women’s health, a dramatically underserved and underinvested segment.

The holder of 11 issued patents, Karen received her MBA from the Graduate School of Business, Stanford University and her BSE in Chemical Engineering from Princeton University.